| Alyson Kate Spencer-stewart, | |
|
8340 Mission Rd Unit B, Leawood, KS 66206-1355 | |
| (913) 213-3531 | |
| Not Available |
| Full Name | Alyson Kate Spencer-stewart |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 8340 Mission Rd Unit B, Leawood, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184488264 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | T-06086 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alyson Kate Spencer-stewart, 7653 Rainbow Dr, Prairie Village, KS 66208-3654 Ph: (913) 633-2433 | Alyson Kate Spencer-stewart, 8340 Mission Rd Unit B, Leawood, KS 66206-1355 Ph: (913) 213-3531 |
News Archive
Isolating cells from a patient's blood or bone marrow that nourish blood vessels may be a safer and less arduous route to treatment of cardiovascular disease than obtaining rare stem cells, according to research from Emory University School of Medicine. In recent clinical trials, doctors in several countries have tested the ability of a patient's bone marrow cells to repair damage, such as heart attacks and peripheral artery disease, created by problems of blood flow.
Orexigen Therapeutics, Inc. today announced that its 24-week, Phase 2b trial for Empatic(TM) (bupropion SR/zonisamide SR), the Company's second late stage investigational combination drug for the treatment of obesity, met its primary efficacy endpoint by demonstrating statistically significantly greater weight loss for both Empatic doses compared to monotherapies and placebo.
Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings related to the human microbiome, announced today that it has closed its $10 million Series B financing that included existing investors Flagship Ventures and Enso Ventures, and included new investors, Mayo Clinic, Alexandria Venture Investments, and several private investors. The company has also entered into an exclusive research collaboration with the Mayo Clinic.
Mayo Clinic today announced that Shriners Hospitals for Children - Twin Cities (Shriners) will build on the decades-long collaboration between physicians in both organizations and become part of the Mayo Clinic Care Network.
Life BioScience, Inc. has launched a new Life MicroFab™ Division that provides a broad range of micro-fabrication services for devices made in APEX Glass, APEX Ceramic, Silicon, Pyrex, SOI, Kapton and other standard materials used in the semiconductor manufacturing process.
› Verified 3 days ago
Katelyn Marie Wiedeman, OTR/L, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3651 College Blvd Ste 110, Leawood, KS 66211 Phone: 913-253-8980 Fax: 913-253-1760 | |
Dr. Lindsay Christine Boten, OTD, OTR/L, CLT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 11624 Tomahawk Creek Pkwy, Unit G, Leawood, KS 66211 Phone: 913-449-0487 | |
Allie Mullender, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3715 W 133rd St, Leawood, KS 66209 Phone: 913-213-3531 | |
Christy Elizabeth Krebs, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3651 W 111th St, Leawood, KS 66211 Phone: 913-253-8980 | |
Allison Rae Howard, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5204 W 128th St, Leawood, KS 66209 Phone: 913-766-3514 | |
Sarah Aleene Knorr, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 4400 W 115th St, Leawood, KS 66211 Phone: 913-491-3681 | |
Dr. Kris M Vacek, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 8900 State Line Rd, Ste. 333, Leawood, KS 66206 Phone: 913-491-9404 Fax: 913-754-0365 |